Article Details
Retrieved on: 2022-12-30 11:10:18
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
On November 17, Provention Bio's Tzield (teplizumab-mzwv) received FDA approval as an injection to delay the onset of stage 3 type 1 diabetes in ...
Article found on: www.geneonline.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here